UNIVERSITY OF UTAH

A randomized clinical trial involving 757 participants found that the complete multicomponent Symptom Care at Home intervention, including automated self-management coaching and clinician follow-up for moderate and severe symptoms, achieved the greatest reduction in symptom burden compared to individual components alone. This suggests that multicomponent digital approaches to cancer symptom management offer optimal symptom burden reduction during chemotherapy treatment.

Dr. Amanda Piquet discusses stiff-person syndrome, a rare autoimmune neurologic disorder, its symptoms, diagnostic challenges, and current and future treatments. She highlights her role as the inaugural chairholder of the Céline Dion Foundation Endowed Chair in Autoimmune Neurology and her research program focused on advancing understanding and treatment of these conditions.

Researchers at Huntsman Cancer Institute developed a mechanism using PDX models to predict TNBC aggressiveness, potentially revolutionizing treatment by identifying higher-risk patients and tailoring precise treatments.

Scientists at Huntsman Cancer Institute developed a new mechanism using PDX models to predict TNBC aggressiveness, potentially revolutionizing treatment by identifying higher-risk patients and tailoring precise treatments. This method is more accurate than existing ones in forecasting TNBC recurrence, offering hope for more personalized and effective treatment strategies.